C
Classys Inc
KOSDAQ:214150
Classys Inc
KOSDAQ:214150
Price:
53 000
KRW
1.34%
Market Closed
Market Cap:
₩3.5T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Classys Inc
KOSDAQ:214150
|
KR |
|
Time Out Group PLC
LSE:TMO
|
UK |
|
O
|
OE Solutions Co Ltd
KOSDAQ:138080
|
KR |
Multiples-Based Value
The Multiples-Based Value for Classys Inc (214150) under the Base Case is 37 807.95 KRW. Compared with the current market price of 53 000 KRW, the stock appears Overvalued by 29%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Base Case
37 807.95
KRW
Overvaluation 29%
C
Multiples Across Competitors
Competitors Multiples
Classys Inc Competitors
Classys Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
C
|
Classys Inc
KOSDAQ:214150
|
3.4T KRW | 10.9 | 29.3 | 21.4 | 23.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
178.6B USD | 4 | 27.4 | 15.7 | 21.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.5B USD | 15.9 | 56.2 | 42.5 | 52.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
126.8B USD | 5 | 39.1 | 20 | 24.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.2B USD | 3.1 | 24.1 | 13.3 | 19.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
93.2B USD | 4.6 | 32.1 | 19.1 | 25.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.1B USD | 7.8 | 43.9 | 24.1 | 26.4 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.6B EUR | 1.7 | 19.2 | 10.8 | 15.3 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.4B USD | 10.6 | 42.9 | 30.4 | 33.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44B USD | 2 | 25 | 9.9 | 16.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.6B USD | 6 | 22 | 15.4 | 17.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
